30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

DePuy Synthes Reports 1Q19 Revenue of $2,203MM, -2.1% vs. 1Q18 -

By Mike Evers, ORTHOWORLD

DePuy Synthes reported 1Q19 orthopaedic revenue of USD $2,203MM, -2.1% vs. 1Q18.

  • Knee sales were impacted by competitive pressure in the U.S. coupled with declines in EMEA, which were partially offset by increasing uptake of ATTUNE Revision
  • Hip sales were supported by strong market demand for the ACTIS stem
  • Spine regressed on base business declines
  • In trauma, new products like Femoral Recon Nails gained traction supported by a growing market
  • Sports Medicine saw double-digit growth in Asia Pacific
  • Completed acquisition of Auris Health to enhance digital surgery capabilities, expects the addition to complement Orthotaxy

 

ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM).

  1Q19 1Q18 $ Chg % Chg
Joint Replacement $846.3 $867.9 -$21.6 -2.5%
Knees $374.4 $393.2 -$18.8 -4.8%
Hips $370.5 $369.2 $1.3 0.3%
Extremities $101.5 $105.5 -$4.0 -3.8%
Spine $354.4 $360.5 -$6.1 -1.7%
Trauma $654.3 $663.9 -$9.6 -1.4%
Sports Medicine $169.5 $167.6 $1.9 1.1%
Orthobiologics $94.7 $101.3 -$6.6 -6.5%
Other (CMF) $83.6 $88.9 -$5.3 -5.9%
Total  $2,203.0 $2,250.1 -$47.1 -2.1%

ORTHOWORLD estimates orthopaedic sales by geographic region as follows ($MM).

Geographic Region 1Q19 1Q18 $ Chg % Chg
US $1,317.97 $1,307.06 $10.9 0.8%
Ex-US $884.98 $943.04 -$58.1 -6.2%
   EMEA $398.24 $424.37 -$26.1 -6.2%
   Asia Pacific $314.17 $330.06 -$15.9 -4.8%
   Rest of World $172.57 $188.61 -$16.0 -8.5%
Total  $2,203.0 $2,250.1 -$47.1 -2.1%

Net earnings for all Johnson & Johnson revenue are as follows.

1Q19 Amount ($MM) % of Sales
Sales $20,021.0  
   Cost of Sales -$6,615.0 33.0%
   Selling and Admin -$5,219.0 26.1%
   R & D -$3,748.0 18.7%
   Other -$690.0 3.4%
Net Earnings  $3,749.0 18.7%

 

Sources: DePuy Synthes Companies of Johnson & Johnson; ORTHOWORLD estimates.

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.